We sincerely welcome Professor Robert Zorec from University of Ljubljana, Medical Faculty, Slovenia, to join the Editorial Board of OBM Neurobiology. Professor Zorec has extensive experience in cell physiology and pathophysiology, biophysics, neuroscience, neuroglia, neurodegeneration, neurodevelopmental disorders, neuroinflammaton and neurotrauma. We are sincerely grateful to Professor Zorec for his participation and support.

We sincerely welcome Dr Barbara Picconi, from IRCCS Fondazione Santa Lucia, Italy, to join the Editorial Board of OBM Neurobiology. Dr. Picconi has abundant professional experience in electrophysiology, neurodegenerative disorders, neuroscience, experimental models of parkinson's disease, levodopa-induced dyskinesia. We appreciate Dr. Picconi for her participation and support.

We sincerely welcome Dr. Weiwen Wang, from Institute of Psychology, China, to join the Editorial Board of OBM Neurobiology. Dr. Wang has abundant professional experience in early stress, depression, schizophrenia, cognitive dysfunction, psychoneuroimmunology, molecular neuroscience. We appreciate Dr. Wang for his participation and support.

We sincerely welcome Dr. Luigi De Gennaro, from University of Rome Sapienza, Italy, to join the Editorial Board of OBM Neurobiology. Dr. Gennaro has abundant professional experience in sleep, sleep in neurodegenerative diseases, sleep regulation, neurophysiology of sleep, sleep disorders, dream recall, ontogenetic aspects of sleep, sleepiness, sleep deprivation. We appreciate Dr. Gennaro for his participation and support.

We sincerely welcome Professor Bart Ellenbroek, from Victoria University of Wellington, New Zealand, to lead the journal OBM Neurobiology as the Editor-in-Chief. Professor Ellenbroek is an expert specializing in behavioural neurogenetics. He and his group focus on the aetiology and neurobiology of symptoms related to several psychiatric disorders. We are grateful to Professor Ellenbroek for his participation and support.

We sincerely welcome Dr. Guodong Cao, from University of Pittsburgh, USA, to join the Editorial Board of OBM Neurobiology. Dr. Cao and his team seek to research on neuronal cell death mechanism, neurovascular remodeling, white matter injury and stem cell therapy in ischemic stroke and exploration of therapeutic approaches for the treatment of ischemic stroke. We appreciate Dr. Cao for his participation and support.

We sincerely welcome Professor Sangeeta Singg, from Angelo State University, USA, to join the Editorial Board of OBM Neurobiology. Professor Singg has abundant professional experience in post-traumatic stress disorder, depression, zoophilia, childhood sexual abuse, memory, cardiovascular disease, alternative methods of healing, grief, suicide, energy medicine, student personal responsibility, self-esteem, color preference and color therapy, role of nutrition in physical and psychological wellness. Dr. Singg organized the first AIDS Awareness Program in West Texas in early 1980s and started the first support group for the AIDS patients, their families and friends. We appreciate Professor Singg for her participation and support.

We sincerely welcome Dr. Michael C. Wu, from University of California, San Diego, USA and President of Neurodigitech, to join the Editorial Board of OBM Neurobiology. Dr. Wu and his team seek to develop the high-throughput digital imaging platform to disclose the diversity of morphological properties and identify the best therapeutic biomarkers for neurodegenerative diseases. Moreover, his additional effort has been dedicated to the development of effective brain-computer-interface (BCI) devices for the early diagnosis of TBI (traumatic brain injury). We appreciate Dr. Wu for his participation and support.

We sincerely welcome Professor Mirela Olympia Fagarasan Palmer, from University of South California, USA, to join the Editorial Board of OBM Neurobiology. Professor Palmer and her team seek to understand the fundamental neurobiological mechanisms of neuropsychiatric disorders to contribute at development of new pharmacological treatments. We appreciate Professor Palmer for her participation and support.

We sincerely welcome Professor Miguel A Pappolla, from the University of Texas Medical Branch, Galveston, TX, and the Texas Medical Center at Houston, TX, USA, to join the Editorial Board of OBM Neurobiology. Professor Pappolla and his team was among the first to identify evidence of oxidative stress in Alzheimer's disease brain, conducted groundbreaking research on hypercholesterolemia as an early risk factor for Alzheimer's disease. His research involves the development of neuroprotective drugs as potential therapeutic agents. Dr. Pappolla's lab identified of several naturally occurring neuroprotective substances. This discovery provides a biochemical basis, at least in part, for the gut-brain axis. We appreciate Professor Pappolla for his participation and support.